Literature DB >> 6287536

Prostaglandins: specific inhibition of platelet adhesion to collagen and relationship with cAMP level.

A Karniguian, Y J Legrand, J P Caen.   

Abstract

The effect of 3 prostaglandins (PG's) (I2, D2 and E1) on the adhesion of platelets to purified type III collagen has been investigated. A quantitative method for a specific evaluation of the adhesion has been applied and has revealed an inhibition of adhesion by low concentrations (10(-10)M) of PGs added before collagen; the effect varied as a function of the dose of PGs (maximum at 10(-6)M) which also induced an increase in the level of platelet cAMP. The inhibition of adhesion and the elevation of platelet cAMP followed the same time course and were either of short duration (rapid decrease in the induced effects after 15 and 45 seconds in the case of PGE1) or longer lasting (maximum effect maintained for 5 minutes in the case of PGI2 and D2). These effects were potentiated by a phosphodiesterase inhibitor such as theophylline (10(-3)M). The addition of PGs after collagen resulted in a reduction of the enhancement of cAMP, associated with a decrease in the inhibition of adhesion. Moreover, the addition of exogenous cAMP (dibutyryl N6-02' cAMP) induced a comparable inhibition. A correlation between the adhesion of platelets to collagen and the level of either endogenous or exogenous cAMP has been established. The PGs also inhibited the platelet release reaction from the alpha granules (beta TG) and the dense bodies. (5-HT and ADP). A greater inhibition of release than of adhesion was observed for the same doses of PGs added.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287536     DOI: 10.1016/0090-6980(82)90108-3

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  6 in total

1.  The antiplatelet activity of PMC, a potent alpha-tocopherol analogue, is mediated through inhibition of cyclo-oxygenase.

Authors:  J R Sheu; C R Lee; C C Lin; Y C Kan; C H Lin; W C Hung; Y M Lee; M H Yen
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Low concentration of oxidized low density lipoprotein suppresses platelet reactivity in vitro: an intracellular study.

Authors:  Duen-Suey Chou; George Hsiao; Ming-Yi Shen; Tsorng-Harn Fong; Chien-Huang Lin; Tzeng-Fu Chen; Joen-Rong Sheu
Journal:  Lipids       Date:  2004-05       Impact factor: 1.880

3.  Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies.

Authors:  Joen R Sheu; Tsorng H Fong; Cheng M Liu; Ming Y Shen; Ta L Chen; Yi Chang; Meng S Lu; George Hsiao
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

4.  Effect of trilinolein on cyclic nucleotide formation in human platelets: relationship with its antiplatelet effect and nitric oxide synthesis.

Authors:  Y C Shen; C Y Hong
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

5.  Antiproliferative effects of A02011-1, an adenylyl cyclase activator, in cultured vascular smooth muscle cells of rat.

Authors:  S M Yu; Z J Cheng; S C Kuo
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

6.  COX-2 Inhibition by Use of Rofecoxib or High Dose Aspirin Enhances ADP-Induced Platelet Aggregation in Fresh Blood.

Authors:  Piet Borgdorff; M Louis Handoko; Yeun Ying Wong; Geert Jan Tangelder
Journal:  Open Cardiovasc Med J       Date:  2010-10-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.